Changing peptide prescribers: how to transfer care

Ask the previous service for visit notes, diagnosis, relevant test results, prescription history, and follow-up plan. Bring your own medicine list, including any research-use or compounded products you used. AHRQ stresses that clinicians need a complete medication history to prevent interaction and treatment errors. Do not assume the new clinician can see the old platform’s records. AHRQ: Talk with your doctor

Similar names can hide differences in formulation and status. Give the new prescriber the label and pharmacy information rather than saying only “the peptide.” FDA’s current label resources allow verification of approved products. If a compounded preparation was used, explain why it was chosen and whether an approved option was assessed; the new clinician may need to revisit that decision. FDA: Learn about your medicines FDA: Compounding and the FDA Q&A

Record the outcome you hoped for, what changed, side effects, missed doses or gaps, and any practical barriers such as cost. AHRQ’s shared-decision approach includes preferences and tradeoffs, so a new plan should account for what made the previous one workable or not. A new clinician may ask for more evaluation before continuing treatment; that is a clinical decision rather than a clerical transfer. AHRQ: SHARE approach

Ask how the prescription and pharmacy will be handled during the transition and who is responsible for problems until the new clinician accepts care. Do not use a research-use product to cover a gap. If an urgent symptom or potential medication reaction occurs, seek appropriate care and provide the product details. FDA’s MedWatch resource explains how suspected problems can also be reported. FDA: Reporting serious problems

Ask: Is the original diagnosis adequately established? Does the exact medicine still fit the evidence and my history? What information is missing before a safe continuation decision? These questions let the new clinician acknowledge uncertainty without either rubber-stamping or dismissing prior care. Bring the old label and a timeline of benefits and problems. AHRQ: SHARE approach

Confirm whether the old prescription can be transferred, whether a new prescription is required, and which pharmacy will dispense. State licensure and product-specific rules can affect the answer, so ask the actual pharmacy rather than relying on a platform’s generic help page. Keep enough lead time for records and authorization review. If treatment cannot safely continue, the new clinician should explain the care plan for the underlying condition. FDA: Locate a state-licensed online pharmacy